|
Alemtuzumab
|
Visite: 193
|
|
Altretamine
|
Visite: 388
|
|
Aminoglutetimide
|
Visite: 343
|
|
L'Acido 5-Aminolevulinico
|
Visite: 298
|
|
Idrossicarbamide
|
Visite: 204
|
|
Anastrozole
|
Visite: 371
|
|
Arsenico Triossido Di
|
Visite: 367
|
|
Asparaginasi
|
Visite: 326
|
|
Bevacizumab
|
Visite: 217
|
|
Bexarotene
|
Visite: 366
|
|
Bleomicina
|
Visite: 363
|
|
Busulfan
|
Visite: 327
|
|
Capecitabina
|
Visite: 340
|
|
Carboplatino
|
Visite: 395
|
|
Carmustina
|
Visite: 390
|
|
Cetuximab
|
Visite: 238
|
|
Ciclofosfamide
|
Visite: 355
|
|
Cisplatino
|
Visite: 231
|
|
La citarabina
|
Visite: 210
|
|
Cladribina
|
Visite: 230
|
|
Chlorambucil
|
Visite: 344
|
|
Chlormethinum
|
Visite: 492
|
|
Dacarbazina
|
Visite: 185
|
|
Dactinomicina
|
Visite: 236
|
|
Daunorubicina
|
Visite: 192
|
|
Docetaxel
|
Visite: 183
|
|
Doxorubicina
|
Visite: 394
|
|
Epirubucin
|
Visite: 179
|
|
Erlotinib
|
Visite: 314
|
|
Etoposide
|
Visite: 231
|
|
Exemestano
|
Visite: 386
|
|
Fluorouracile Topico Soluzione
|
Visite: 167
|
|
Fluorouracile
|
Visite: 238
|
|
Gemcitabina
|
Visite: 177
|
|
Idarubicina-Hcl
|
Visite: 338
|
|
Ifosfamide
|
Visite: 197
|
|
Melfalan
|
Visite: 175
|
|
Mercaptopurina
|
Visite: 321
|
|
Methotrexate
|
Visite: 269
|
|
Mitomicina
|
Visite: 282
|
|
Mitoxantrone
|
Visite: 174
|
|
Oxaliplatino
|
Visite: 152
|
|
Paclitaxel
|
Visite: 214
|
|
Pentostatina
|
Visite: 217
|
|
Procarbazina
|
Visite: 209
|
|
Rituximab
|
Visite: 233
|
|
Teniposide
|
Visite: 173
|
|
Tioguanina
|
Visite: 165
|
|
Tiotepa
|
Visite: 173
|
|
Trastuzumab
|
Visite: 226
|
|
Tretinoin Orale
|
Visite: 332
|
|
Vinblastina
|
Visite: 184
|
|
Vincristina
|
Visite: 174
|
|
Vinorelbine Tartrate
|
Visite: 200
|
|
Everolimus
|
Visite: 199
|
|
Imatinib Mesilato
|
Visite: 188
|
|
Nilotinib
|
Visite: 232
|
|
Dasatinib
|
Visite: 195
|
|
Pazopanib
|
Visite: 169
|
|
Ipilimumab
|
Visite: 168
|
|
Nivolumab
|
Visite: 211
|
|
Brentuximab Vedotin
|
Visite: 197
|